Related Experiment Video
Updated: Oct 12, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Structural basis for ligand reception by anaplastic lymphoma kinase
Tongqing Li1,2, Steven E Stayrook1,2, Yuko Tsutsui1,2
1Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Anaplastic lymphoma kinase (ALK) structure reveals how its glycine-rich domain regulates receptor activity. This finding offers new therapeutic strategies for ALK-driven cancers, including pediatric neuroblastoma.
Area of Science:
- Molecular biology
- Structural biology
- Cancer research
Background:
- Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase crucial for nervous system development.
- Post-development, ALK influences learning, memory, and energy expenditure, with inhibition preventing obesity.
- Aberrant ALK signaling drives various cancers, notably pediatric neuroblastoma.
Purpose of the Study:
- To elucidate the structural basis of ALK regulation by its extracellular glycine-rich domain (GRD).
- To understand how ALK responds to regulatory ligands and forms dimeric complexes.
- To identify potential therapeutic targets for ALK-related malignancies.
Main Methods:
- X-ray crystallography to determine the structure of the ALK GRD.
- Engineering a fusion protein of ALK GRD and its ligand to capture dimeric complexes.
- Site-directed mutagenesis of the polyglycine extension loop (PXL) and antibody interaction studies.
Main Results:
- Revealed crystal structures of the ALK GRD, detailing its role in regulating receptor activity.
- Demonstrated that repetitive glycines in the GRD form rigid helices, separating ligand-binding sites from the PXL.
- Identified the PXL as the key mediator of ALK dimerization and inter-receptor signaling.
Conclusions:
- The atypical architecture of ALK, particularly the PXL, is central to its ligand-mediated regulation.
- Disrupting PXL function via mutation or antibodies can abolish ALK activation.
- These findings present novel therapeutic avenues for cancers driven by ALK, such as pediatric neuroblastoma.
Related Concept Videos
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Amplifying Signals via Enzymatic Cascade
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway

